AptarGroup, Inc. (ATR) Stock Analysis — Probabli.AI
AI-powered analysis for ATR (AptarGroup, Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. Latest AI outlook: Bullish.
Last price: $130.64 · Market cap: $8.1B · AI outlook: Bullish
AptarGroup (ATR) represents an elite specialty packaging compounder operating primarily as a mission-critical pharmaceutical drug delivery developer with defensive consumer dispensing operations. Trading at $130.64 with an $8.1B market capitalization, the company trades at a reasonable valuation given its extraordinary track record of eight consecutive quarters of earnings beats and an average…
Probabilistic 1-Year Outlook
- Bull 60% · Neutral 28% · Bear 12%
- 1-year price estimates — P10: $110 / P50: $150 / P90: $172
- AptarGroup possesses a formidable high-margin moat in proprietary pharmaceutical drug delivery devices and specialty packaging. An eight-quarter earnings beat streak, an ongoing +5.9% average EPS surprise, steady…
5-Year Outlook
- Bull 65% · Neutral 23% · Bear 12%
- 5-year price estimates — P10: $145 / P50: $222 / P90: $295
SWOT Highlights
- Strength: Proprietary drug delivery device portfolio with entrenched FDA/EMA DMF filings and high switching barriers
- Strength: Exceptional operational execution highlighted by an 8-quarter consecutive earnings beat streak and +5.9% average EPS surprise
- Risk: Muted cyclical revenue growth in non-pharma consumer segments (projected at 1.4% near-term)
- Risk: High reliance on raw material resin prices and energy inputs influencing gross margin variability
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
9 Wall Street analysts rate ATR a BUY with a mean price target of $150.8. AptarGroup, Inc. currently pays a dividend with a yield of approximately 1.47%.
Last analyzed · Model: gemini-3.8-flash. How this forecast works · Accuracy & validation.
ATR forecast details · ATR sentiment details · ATR insider activity
Recent saved forecast research
AI-generated research records, not evaluated investment results.
- AptarGroup, Inc. (ATR) — saved
AptarGroup (ATR) represents an elite specialty packaging compounder operating primarily as a mission-critical pharmaceutical drug delivery developer with defensive consumer dispensing operations. Trading at $130.64 with an $8.1B market capi
- AptarGroup, Inc. (ATR) — saved
AptarGroup, Inc. showcases strong potential for growth due to its innovative product portfolio, global expansion strategy, and alignment with sustainability trends. While there are challenges including supply chain risks and competitive pre
- AptarGroup, Inc. (ATR) — saved
AptarGroup, Inc. is well-positioned for long-term growth, supported by solid financial performance, innovative product lines, and strong industry partnerships. Despite potential risks such as market competition and external macroeconomic pr
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.